These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
593 related articles for article (PubMed ID: 19026028)
21. Statins, neuromuscular degenerative disease and an amyotrophic lateral sclerosis-like syndrome: an analysis of individual case safety reports from vigibase. Edwards IR; Star K; Kiuru A Drug Saf; 2007; 30(6):515-25. PubMed ID: 17536877 [TBL] [Abstract][Full Text] [Related]
22. Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system? Sessa M; Rafaniello C; Scavone C; Mascolo A; di Mauro G; Fucile A; Rossi F; Sportiello L; Capuano A Expert Opin Drug Saf; 2018 May; 17(5):457-465. PubMed ID: 29619841 [TBL] [Abstract][Full Text] [Related]
23. Ticlopidine safety profile: a case/non-case study on the basis of the spontaneous ADRs reporting in Italy. Motola D; Biagi C; Leone R; Venegoni M; Lapi F; Cutroneo P; Vargiu A; Bonaiuti R; Montanaro N; Vaccheri A Curr Drug Saf; 2012 Apr; 7(2):99-105. PubMed ID: 22873494 [TBL] [Abstract][Full Text] [Related]
24. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Lapi F; Tuccori M; Motola D; Pugi A; Vietri M; Montanaro N; Vaccheri A; Leoni O; Cocci A; Leone R; Conforti A; Moretti U; Sessa E; Mazzaglia G; Mugelli A; Mazzei T; Vannacci A Drug Saf; 2010 Sep; 33(9):789-99. PubMed ID: 20701411 [TBL] [Abstract][Full Text] [Related]
25. Risk of diabetes with fibrates and statins: a pharmacoepidemiological study in VigiBase Montastruc F; Benevent J; Rousseau V; Durrieu G; Sommet A; Montastruc JL Fundam Clin Pharmacol; 2019 Feb; 33(1):108-112. PubMed ID: 30098074 [TBL] [Abstract][Full Text] [Related]
26. Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database. Boonmuang P; Nathisuwan S; Chaiyakunapruk N; Suwankesawong W; Pokhagul P; Teerawattanapong N; Supsongserm P Drug Saf; 2013 Sep; 36(9):779-87. PubMed ID: 23615756 [TBL] [Abstract][Full Text] [Related]
27. Vaccine-based subgroup analysis in VigiBase: effect on sensitivity in paediatric signal detection. de Bie S; Verhamme KM; Straus SM; Stricker BH; Sturkenboom MC Drug Saf; 2012 Apr; 35(4):335-46. PubMed ID: 22435344 [TBL] [Abstract][Full Text] [Related]
28. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use. Fraunfelder FW; Richards AB Ophthalmology; 2008 Dec; 115(12):2282-5. PubMed ID: 18930555 [TBL] [Abstract][Full Text] [Related]
29. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
30. Statin-induced lupus: a case/non-case study in a nationwide pharmacovigilance database. Moulis G; Béné J; Sommet A; Sailler L; Lapeyre-Mestre M; Montastruc JL; Lupus; 2012 Jul; 21(8):885-9. PubMed ID: 22333565 [TBL] [Abstract][Full Text] [Related]
31. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database. Welch HK; Kellum JA; Kane-Gill SL Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524 [TBL] [Abstract][Full Text] [Related]
32. Pregnancy-related adverse events associated with statins: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System (FAERS). Wu T; Shi Y; Zhu B; Li D; Li Z; Zhao Z; Zhang Y Expert Opin Drug Saf; 2024 Mar; 23(3):313-321. PubMed ID: 37612600 [TBL] [Abstract][Full Text] [Related]
33. Allergic reactions to oral drugs: A case/non-case study from an Italian spontaneous reporting database (GIF). Salvo F; Polimeni G; Cutroneo PM; Leone R; Confortic A; Moretti U; Motola D; Tuccori M; Caputi AP Pharmacol Res; 2008; 58(3-4):202-7. PubMed ID: 18692136 [TBL] [Abstract][Full Text] [Related]
34. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Golomb BA; McGraw JJ; Evans MA; Dimsdale JE Drug Saf; 2007; 30(8):669-75. PubMed ID: 17696579 [TBL] [Abstract][Full Text] [Related]
35. Drug-related nephrotoxic and ototoxic reactions : a link through a predictive mechanistic commonality. Verdel BM; van Puijenbroek EP; Souverein PC; Leufkens HG; Egberts AC Drug Saf; 2008; 31(10):877-84. PubMed ID: 18759511 [TBL] [Abstract][Full Text] [Related]
36. Statin-related neurocognitive disorder: a real-world pharmacovigilance study based on the FDA adverse event reporting system. Xiao M; Li L; Zhu W; Wu F; Wu B Expert Rev Clin Pharmacol; 2024 Mar; 17(3):255-261. PubMed ID: 38275183 [TBL] [Abstract][Full Text] [Related]
37. Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database. Takada M; Fujimoto M; Yamazaki K; Takamoto M; Hosomi K Drug Saf; 2014 Jun; 37(6):421-31. PubMed ID: 24743876 [TBL] [Abstract][Full Text] [Related]
38. Patient versus healthcare professional spontaneous adverse drug reaction reporting: a systematic review. Inch J; Watson MC; Anakwe-Umeh S Drug Saf; 2012 Oct; 35(10):807-18. PubMed ID: 22928729 [TBL] [Abstract][Full Text] [Related]
39. Drug-induced taste and smell alterations: a case/non-case evaluation of an italian database of spontaneous adverse drug reaction reporting. Tuccori M; Lapi F; Testi A; Ruggiero E; Moretti U; Vannacci A; Bonaiuti R; Antonioli L; Fornai M; Giustarini G; Scollo C; Corona T; Ferrazin F; Sottosanti L; Blandizzi C Drug Saf; 2011 Oct; 34(10):849-59. PubMed ID: 21879779 [TBL] [Abstract][Full Text] [Related]
40. Analysis of National Pharmacovigilance Data Associated with Statin Use in Korea. Kim H; Kim N; Lee DH; Kim HS Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):409-413. PubMed ID: 28500776 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]